The Online Investor
Stock Buybacks
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Stock Buybacks

By The Online Investor Staff, updated Sat., Oct. 25, 8:39 AM

Slide #3. Pfizer Inc.

Company: Pfizer Inc. (NYSE:PFE)
$Amount Authorized: $11,000,000,000
Buyback Details: The board of directors also authorized a new $11 billion share repurchase program to be utilized over time. This new program is in addition to the $1.3 billion of authorization remaining under the company's current share repurchase program.

Pfizer is a research-based biopharmaceutical company involved in the discovery, development and manufacture of healthcare products. Co.'s businesses include: Global Innovative Pharmaceutical business, which comprises medicines within several therapeutic areas including immunology and inflammation, rare diseases and women's/men's health; Global Vaccines, Oncology and Consumer Healthcare business, which focuses on the development and commercialization of vaccines and products for oncology and consumer healthcare; and Global Established Pharmaceutical business, which includes brands that have lost market exclusivity and, generally mature, patent-protected products, and generic pharmaceuticals.
Open the PFE Page at The Online Investor »

Company Name:  Pfizer Inc
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding PFE:  103
Total Market Value Held by ETFs:  $7.26B
Total Market Capitalization:  $179.45B
% of Market Cap. Held by ETFs:  4.05%

Open the PFE Page at The Online Investor (in a new window) »

October 25, 2014    8:39 AM Eastern
Quotes delayed 20 minutes

Buy (3.00 out of 4)
43rd percentile
(ranked lower than approx. 57% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Buybacks | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.